翰森制药：新药HS-10582片临床试验获批

财中社08-06

8月6日，翰森制药（03692）发布公告，本公司自主研发的1类新药HS-10582片获得中国国家药品监督管理局签发的药物临床试验批准通知书。该药物拟用于治疗成人原发性高胆固醇血症和混合型血脂异常的临床试验。（文章来源：财中社）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2657334316?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-06 19:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657334316","market":"us","top_or_hot":-1,"title":"翰森制药：新药HS-10582片临床试验获批","media":"财中社","content":"<div>\n<p>8月6日，翰森制药（03692）发布公告，本公司自主研发的1类新药HS-10582片获得中国国家药品监督管理局签发的药物临床试验批准通知书。该药物拟用于治疗成人原发性高胆固醇血症和混合型血脂异常的临床试验。（文章来源：财中社）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202608063834021815.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>翰森制药：新药HS-10582片临床试验获批</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n翰森制药：新药HS-10582片临床试验获批\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-06 19:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202608063834021815.html><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月6日，翰森制药（03692）发布公告，本公司自主研发的1类新药HS-10582片获得中国国家药品监督管理局签发的药物临床试验批准通知书。该药物拟用于治疗成人原发性高胆固醇血症和混合型血脂异常的临床试验。（文章来源：财中社）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202608063834021815.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"http://finance.eastmoney.com/a/202608063834021815.html","article_id":"2657334316","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608063834021815.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2657334316","pubTimestamp":1786014720,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"8月6日，翰森制药（03692）发布公告，本公司自主研发的1类新药HS-10582片获得中国国家药品监督管理局签发的药物临床试验批准通知书。该药物拟用于治疗成人原发性高胆固醇血症和混合型血脂异常的临床试验。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1583":"高瓴概念","PSYK":"PSYK ETF","03692":"翰森制药","BK1589":"北水核心资产","IBBQ":"Invesco Nasdaq Biotechnology ETF","BK1191":"制药","IBBJ":"Defiance Nasdaq Junior Biotechnology ETF","BMED":"iShares Health Innovation Active ETF","MDTX":"Corgi MediaTek 2x Daily ETF"},"translate_title":"Hansen Pharmaceuticals: Clinical trial of new drug HS-10582 tablets approved","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBBJ":1.5,"MDTX":1.5,"PSYK":1.5,"03692":1.5,"IBBQ":1.5,"BMED":1.5},"content_text":"8月6日，翰森制药（03692）发布公告，本公司自主研发的1类新药HS-10582片获得中国国家药品监督管理局签发的药物临床试验批准通知书。该药物拟用于治疗成人原发性高胆固醇血症和混合型血脂异常的临床试验。（文章来源：财中社）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2657334316","isCrawlerRequest":true}